Results 21 to 30 of about 137,343 (204)
Treatment of Vogt-Koyanagi-Harada Disease [PDF]
Cureus, 2020 Vogt-Koyanagi-Harada (VKH) disease is a T-cell-mediated autoimmune inflammatory disease characterized by granulomatous panuveitis with a variety of other systemic manifestations. A 29-year-old man referred with a two-week history of pain, redness, photophobia, and blurring of vision of the right eye.
Alaql, Musab K +2 more
openaire +2 more sources
Vogt-Koyanagi-Harada Disease and COVID
Journal of Clinical Medicine, 2023 Vogt–Koyanagi–Harada (VKH) is a rare multisystem inflammatory disease affecting the eyes, ears, brain, skin, and hair. The Coronavirus Disease 2019 (COVID-19) is a new contagious infection that might trigger the onset of VKH disease, as previously proposed for other viruses.
Priscilla Manni +2 more
openaire +2 more sources
BMC Ophthalmology, 2020 Background To describe a unique case of pigmented paravenous retinochoroidal atrophy that developed several years after Vogt-Koyanagi-Harada disease. Case presentation A 28-year-old woman presented with gradual vision loss in both eyes and nyctalopia for
Prithvi Ramtohul +3 more
doaj +1 more source
Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report
Journal of Nepal Medical Association, 2022 Vogt-Koyanagi-Harada disease is a multisystem autoimmune inflammatory disorder that affects the eyes, ears, skin, and the nervous system. It is a rare disease that mainly affects Asian, Hispanic, and Middle Eastern populations.
Sagun Khatri +7 more
doaj +1 more source
Communications Biology, 2022 Single-cell RNA-sequencing and chromatin accessibility analysis reveal transcriptomic and epigenomic changes between healthy patients and those affected by the systemic autoimmune disorder Vogt-Koyanagi-Harada disease.
Wen Shi +9 more
doaj +1 more source
Clinical Case Reports, 2017 Key Clinical Message A patient with metastatic cutaneous malignant melanoma developed Vogt‐Koyanagi‐Harada disease‐like posterior uveitis after two nivolumab (anti‐PD‐1 antibody) injections.
Toshihiko Matsuo, Osamu Yamasaki
doaj +1 more source
Unusual Case of Vogt-Koyanagi-Harada Syndrome Presenting as Non-specific Headache [PDF]
Journal of Clinical and Diagnostic Research, 2014 Vogt–Koyanagi–Harada syndrome (VKH) is a bilateral intraocular granulomatous panuveitis which is frequently associated with systemic manifestations such as meningismus, tinnitus, poliosis and vitiligoof autoimmune aetiology. Headache by itself, does not
Pradeep A.V. +4 more
doaj +1 more source
Aplicabilidade do critério diagnóstico revisado de 2001 em pacientes brasileiros com doença de Vogt-Koyanagi-Harada [PDF]
, 2008 PURPOSE: To determine the applicability of the international revised diagnostic criteria for Vogt-Koyanagi-Harada disease. METHODS: Retrospective study.
Zajdenweber, Moysés Eduardo [UNIFESP] +9 more
core +2 more sources
European Journal of Case Reports in Internal Medicine, 2018 Vogt–Koyanagi–Harada disease is rare, mediated by autoimmune melanocyte inflammation and facilitated by genetic predisposition[1-3]. The main clinical features include uveitis, meningitis, tinnitus and sensorineural deafness, and skin and hair ...
Alberto Benavente Fernández +3 more
doaj +1 more source
Uveo-Meningeal Syndromes: Vogt-Koyanagi-Harada (VKH) Disease
, 2023 Ocular inflammatory symptoms with concurrent neuro-ophthalmologic manifestations can be diagnostically challenging. We provide a general overview of uveo-meningeal syndromes, which comprises a heterogeneous group of disorders that involve inflammation of
Rachana Haliyur, MD, PhD; Emily Cole, MD, MPH; Therese Sassalos, MD; Sangeeta Khanna, MD
core